COA1
gene geneOn this page
Also known as FLJ10803MITRAC15
Summary
COA1 (cytochrome c oxidase assembly factor 1, HGNC:21868) is a protein-coding gene on chromosome 7p13, encoding Cytochrome c oxidase assembly factor 1 homolog (Q9GZY4). Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly.
Involved in mitochondrial cytochrome c oxidase assembly and mitochondrial respiratory chain complex I assembly. Located in cytosol and mitochondrial inner membrane.
Source: NCBI Gene 55744 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_018224
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21868 |
| Approved symbol | COA1 |
| Name | cytochrome c oxidase assembly factor 1 |
| Location | 7p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10803, MITRAC15 |
| Ensembl gene | ENSG00000106603 |
| Ensembl biotype | protein_coding |
| OMIM | 614769 |
| Entrez | 55744 |
Gene structure
Transcript identifiers
Ensembl transcripts: 75 — 64 protein_coding, 5 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay, 2 retained_intron
ENST00000223336, ENST00000310564, ENST00000395879, ENST00000415076, ENST00000415798, ENST00000418140, ENST00000420441, ENST00000431651, ENST00000438444, ENST00000446330, ENST00000446564, ENST00000448704, ENST00000451651, ENST00000457939, ENST00000459713, ENST00000470156, ENST00000478504, ENST00000488813, ENST00000490251, ENST00000896974, ENST00000896975, ENST00000896976, ENST00000896977, ENST00000896978, ENST00000896979, ENST00000896980, ENST00000896981, ENST00000896982, ENST00000896983, ENST00000896984, ENST00000896985, ENST00000896986, ENST00000896987, ENST00000896988, ENST00000896989, ENST00000896990, ENST00000896991, ENST00000896992, ENST00000896993, ENST00000896994, ENST00000896995, ENST00000896996, ENST00000896997, ENST00000896998, ENST00000896999, ENST00000897000, ENST00000897001, ENST00000897002, ENST00000934870, ENST00000934871, ENST00000934872, ENST00000934873, ENST00000934874, ENST00000934875, ENST00000934876, ENST00000934877, ENST00000934878, ENST00000934879, ENST00000934880, ENST00000934881, ENST00000934882, ENST00000934883, ENST00000934884, ENST00000934885, ENST00000934886, ENST00000934887, ENST00000934888, ENST00000934889, ENST00000949438, ENST00000949439, ENST00000949440, ENST00000949441, ENST00000949442, ENST00000949443, ENST00000949444
RefSeq mRNA: 27 — MANE Select: NM_018224
NM_001321197, NM_001321198, NM_001321199, NM_001321200, NM_001321201, NM_001321202, NM_001321203, NM_001321204, NM_001321205, NM_001350924, NM_001350925, NM_001350926, NM_001350927, NM_001350928, NM_001371307, NM_001371308, NM_001371309, NM_001371310, NM_001371311, NM_001371312, NM_001371313, NM_001371314, NM_001371315, NM_001371316, NM_001371317, NM_001371318, NM_018224
CCDS: CCDS5471, CCDS83177
Canonical transcript exons
ENST00000223336 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001176880 | 43647535 | 43647634 |
| ENSE00001713359 | 43729429 | 43729523 |
| ENSE00003479589 | 43639257 | 43639681 |
| ENSE00003627047 | 43648600 | 43648652 |
| ENSE00003787087 | 43640573 | 43640649 |
| ENSE00003789929 | 43645251 | 43645399 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 97.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 51.9367 / max 1015.0117, expressed in 1820 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83811 | 50.5321 | 1816 |
| 83810 | 0.8064 | 531 |
| 83809 | 0.3808 | 54 |
| 83805 | 0.2174 | 75 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 97.70 | gold quality |
| oocyte | CL:0000023 | 97.68 | gold quality |
| apex of heart | UBERON:0002098 | 94.51 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.46 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.20 | gold quality |
| endometrium epithelium | UBERON:0004811 | 94.07 | gold quality |
| body of pancreas | UBERON:0001150 | 94.04 | gold quality |
| cardiac ventricle | UBERON:0002082 | 93.96 | gold quality |
| muscle of leg | UBERON:0001383 | 93.84 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.74 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.38 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.85 | gold quality |
| heart | UBERON:0000948 | 92.76 | gold quality |
| right uterine tube | UBERON:0001302 | 92.53 | gold quality |
| pancreas | UBERON:0001264 | 92.45 | gold quality |
| ventricular zone | UBERON:0003053 | 92.42 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.39 | gold quality |
| muscle organ | UBERON:0001630 | 92.35 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 92.35 | gold quality |
| cingulate cortex | UBERON:0003027 | 92.30 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.27 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.21 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.19 | gold quality |
| cardiac atrium | UBERON:0002081 | 92.17 | gold quality |
| colonic epithelium | UBERON:0000397 | 92.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.03 | gold quality |
| left ovary | UBERON:0002119 | 91.75 | gold quality |
| lymph node | UBERON:0000029 | 91.70 | gold quality |
| monocyte | CL:0000576 | 91.66 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7381 | no | 513.51 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting COA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-200A-5P | 99.76 | 69.10 | 949 |
| HSA-MIR-200B-5P | 99.76 | 69.05 | 948 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-145-3P | 99.33 | 67.66 | 764 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-3187-3P | 97.38 | 65.80 | 904 |
| HSA-MIR-550B-2-5P | 96.56 | 64.61 | 646 |
| HSA-MIR-5579-5P | 96.32 | 68.54 | 730 |
| HSA-MIR-193A-5P | 95.70 | 65.33 | 613 |
| HSA-MIR-6503-3P | 93.87 | 66.39 | 348 |
Literature-anchored findings (GeneRIF, showing 5)
- Encodes a mitochondrial protein (PMID:22356826)
- Human ortholog of fungal COA1 (Cytochrome Oxidase Assembly 1) (PMID:22356826)
- Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6. (PMID:26655997)
- MITRAC15/COA1 promotes mitochondrial translation in a ND2 ribosome-nascent chain complex. (PMID:31721420)
- Association of COA1 with Patellar Tendonitis: A Genome-wide Association Analysis. (PMID:34081057)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | coa1 | ENSDARG00000076360 |
| drosophila_melanogaster | CG15653 | FBGN0034578 |
| drosophila_melanogaster | CG31913 | FBGN0051913 |
Protein
Protein identifiers
Cytochrome c oxidase assembly factor 1 homolog — Q9GZY4 (reviewed: Q9GZY4)
Alternative names: Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa
All UniProt accessions (5): C9J6J1, C9JA07, Q9GZY4, F2Z2J3, F8WBS2
UniProt curated annotations — full annotation on UniProt →
Function. Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. MITRAC complexes regulate both translation of mitochondrial encoded components and assembly of nuclear-encoded components imported in mitochondrion. Required for assembly of mitochondrial respiratory chain complex I and complex IV. As part of the MCIA complex, required for efficient assembly of the mitochondrial complex I.
Subunit / interactions. Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, the core components of this complex being COA3/MITRAC12 and COX14. Interacts with COX17 and COA6. Part of the mitochondrial complex I assembly/MCIA complex that comprises at least the core subunits TMEM126B, NDUFAF1, ECSIT and ACAD9 and complement subunits such as COA1 and TMEM186.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the COA1 family.
RefSeq proteins (27): NP_001308126, NP_001308127, NP_001308128, NP_001308129, NP_001308130, NP_001308131, NP_001308132, NP_001308133, NP_001308134, NP_001337853, NP_001337854, NP_001337855, NP_001337856, NP_001337857, NP_001358236, NP_001358237, NP_001358238, NP_001358239, NP_001358240, NP_001358241, NP_001358242, NP_001358243, NP_001358244, NP_001358245, NP_001358246, NP_001358247, NP_060694* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR014807 | Coa1 | Family |
Pfam: PF08695
UniProt features (7 total): sequence conflict 3, topological domain 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZY4-F1 | 88.13 | 0.72 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-611105 | Respiratory electron transport |
| R-HSA-6799198 | Complex I biogenesis |
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 109 (showing top):
BORCZUK_MALIGNANT_MESOTHELIOMA_UP, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY, GOZGIT_ESR1_TARGETS_DN, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, MORF_RAD21, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, MORF_SKP1A, BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN, MORF_ATOX1, GOCC_MITOCHONDRIAL_ENVELOPE, DODD_NASOPHARYNGEAL_CARCINOMA_UP, chr7p13, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (2): mitochondrial respiratory chain complex I assembly (GO:0032981), mitochondrial respiratory chain complex IV assembly (GO:0033617)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), cytosol (GO:0005829), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 2 |
| Aerobic respiration and respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrial respiratory chain complex assembly | 2 |
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| NADH dehydrogenase complex assembly | 1 |
| mitochondrion | 1 |
| respiratory chain complex IV assembly | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
Protein interactions and networks
STRING
502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COA1 | COX14 | Q96I36 | 791 |
| COA1 | COA3 | Q9Y2R0 | 774 |
| COA1 | MSS51 | Q4VC12 | 754 |
| COA1 | SURF1 | Q15526 | 664 |
| COA1 | COX5A | P20674 | 658 |
| COA1 | TMEM186 | Q96B77 | 597 |
| COA1 | ACAD9 | Q9H845 | 589 |
| COA1 | COX15 | Q7KZN9 | 582 |
| COA1 | COX16 | Q9P0S2 | 568 |
| COA1 | NDUFAF5 | Q5TEU4 | 566 |
| COA1 | TIMM21 | Q9BVV7 | 542 |
| COA1 | PET117 | Q6UWS5 | 540 |
| COA1 | COA5 | Q86WW8 | 535 |
| COA1 | SMIM20 | Q8N5G0 | 527 |
| COA1 | PET100 | P0DJ07 | 479 |
IntAct
48 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RNF185 | TMBIM6 | psi-mi:“MI:0914”(association) | 0.740 |
| SLC1A1 | AGPAT2 | psi-mi:“MI:0914”(association) | 0.640 |
| COA3 | MT-CO1 | psi-mi:“MI:0914”(association) | 0.610 |
| SLC9A6 | MAP1LC3B2 | psi-mi:“MI:0914”(association) | 0.530 |
| MCOLN3 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| ECSIT | NDUFS8 | psi-mi:“MI:0914”(association) | 0.530 |
| ZACN | GPAA1 | psi-mi:“MI:0914”(association) | 0.530 |
| NDUFC2 | NDUFS4 | psi-mi:“MI:0914”(association) | 0.530 |
| ACAD9 | PPL | psi-mi:“MI:0914”(association) | 0.530 |
| TIMM21 | TIMM23 | psi-mi:“MI:0914”(association) | 0.500 |
| STK4 | IGHA1 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS6 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| ACAD9 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| POLR2M | BIN1 | psi-mi:“MI:0914”(association) | 0.350 |
| HTR3A | GPAA1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATAD3A | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| TTYH1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNA4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| ATP2A1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| ZACN | FAM234B | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| CRLF2 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A4 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| KDSR | ACOT7 | psi-mi:“MI:0914”(association) | 0.350 |
| MYZAP | BIN1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (51): COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS), COA1 (Affinity Capture-MS)
ESM2 similar proteins: A3KP48, A4IJ20, A8WGU8, B5DF07, D3ZS74, D6WIX5, O14320, P40452, P53220, Q02380, Q08CK1, Q08DT6, Q0MQ83, Q1L987, Q1LY46, Q2NKR7, Q3SZN3, Q3SZV6, Q3ZBC2, Q4HZ95, Q4QQV3, Q4X1I8, Q59VW7, Q5R504, Q5REP2, Q5U2X7, Q5XKA2, Q66JD1, Q6BVK1, Q6CAQ9, Q6CW96, Q6DC58, Q6FMZ2, Q75CX4, Q7S8S5, Q80VP5, Q811I0, Q8CCM6, Q8IQ70, Q8K2Y7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| COA1 | “form complex” | “MITRAC complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 69 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Complex I biogenesis | 7 | 25.8× | 2e-06 |
| Respiratory electron transport | 6 | 12.7× | 9e-04 |
| Aerobic respiration and respiratory electron transport | 5 | 9.8× | 9e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial respiratory chain complex I assembly | 7 | 47.2× | 6e-08 |
| intracellular zinc ion homeostasis | 5 | 39.5× | 4e-05 |
| mitochondrial electron transport, NADH to ubiquinone | 5 | 29.4× | 1e-04 |
| aerobic respiration | 5 | 20.3× | 4e-04 |
| monoatomic ion transmembrane transport | 5 | 17.1× | 9e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2920 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:43619595:A:AG | acceptor_gain | 1.0000 |
| 7:43619596:G:GG | acceptor_gain | 1.0000 |
| 7:43619720:GTGG:G | donor_gain | 1.0000 |
| 7:43619721:TGGG:T | donor_loss | 1.0000 |
| 7:43619722:GG:G | donor_gain | 1.0000 |
| 7:43619723:GG:G | donor_gain | 1.0000 |
| 7:43619723:GGTAA:G | donor_loss | 1.0000 |
| 7:43619724:G:GG | donor_gain | 1.0000 |
| 7:43619724:GTA:G | donor_loss | 1.0000 |
| 7:43619725:TA:T | donor_loss | 1.0000 |
| 7:43619726:AAGTA:A | donor_loss | 1.0000 |
| 7:43623876:T:G | donor_gain | 1.0000 |
| 7:43623884:CCTGA:C | donor_gain | 1.0000 |
| 7:43623885:CTGA:C | donor_gain | 1.0000 |
| 7:43623886:TGA:T | donor_gain | 1.0000 |
| 7:43623887:GA:G | donor_gain | 1.0000 |
| 7:43623887:GAG:G | donor_gain | 1.0000 |
| 7:43623889:G:GG | donor_gain | 1.0000 |
| 7:43623889:GT:G | donor_loss | 1.0000 |
| 7:43623890:T:G | donor_loss | 1.0000 |
| 7:43624515:CA:C | acceptor_loss | 1.0000 |
| 7:43624516:A:AC | acceptor_loss | 1.0000 |
| 7:43624516:A:AG | acceptor_gain | 1.0000 |
| 7:43624517:G:GA | acceptor_gain | 1.0000 |
| 7:43624517:GA:G | acceptor_gain | 1.0000 |
| 7:43624517:GAGA:G | acceptor_gain | 1.0000 |
| 7:43624517:GAGAT:G | acceptor_gain | 1.0000 |
| 7:43645398:CT:C | acceptor_gain | 1.0000 |
| 7:43647635:C:CC | acceptor_gain | 1.0000 |
| 7:43647636:T:C | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000008037 (7:43615780 A>G), RS1000027965 (7:43713844 G>C), RS1000029352 (7:43650832 CAGA>C), RS1000079443 (7:43704547 G>A), RS1000086702 (7:43720054 G>A), RS1000129748 (7:43632436 A>G), RS1000171123 (7:43691744 A>T), RS1000175143 (7:43648323 ATTT>A), RS1000238960 (7:43683590 C>T), RS1000257740 (7:43725881 T>C), RS1000263211 (7:43662289 G>A), RS1000269967 (7:43683354 C>T), RS1000288485 (7:43685511 G>A), RS1000339680 (7:43638514 G>A), RS1000354497 (7:43727396 T>C)
Disease associations
OMIM: gene MIM:614769 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST011743_76 | HDL cholesterol levels in HIV infection | 5.000000e-06 |
| GCST90002397_501 | Mean spheric corpuscular volume | 9.000000e-15 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, decreases expression | 4 |
| bisphenol A | decreases expression, decreases methylation, increases expression | 3 |
| Formaldehyde | decreases expression, increases expression | 2 |
| Nickel | increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| uranyl acetate | affects expression | 1 |
| primycin | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| 1,6-hexamethylene diisocyanate | increases methylation | 1 |
| afimoxifene | decreases expression, decreases reaction | 1 |
| cobaltous chloride | increases expression | 1 |
| mercuric bromide | affects cotreatment, increases expression | 1 |
| bicalutamide | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| ICG 001 | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| PCI 5002 | affects cotreatment, decreases expression | 1 |
| Irinotecan | decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Vorinostat | decreases expression | 1 |
| Panobinostat | affects cotreatment, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | affects expression | 1 |
| Coumestrol | increases expression | 1 |
| Estrogens | decreases expression, decreases reaction | 1 |
| Gasoline | decreases expression, increases abundance, affects cotreatment | 1 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2UQ | Abcam HEK293T COA1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.